ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Injection Drug Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-31N8331
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Injection Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Oncology Injection Drug Market Research Report 2025

Code: QYRE-Auto-31N8331
Report
January 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
ALZA
CordenPharma
Pharmascience

Oncology Injection Drug Market Size

The global market for Oncology Injection Drug was valued at US$ 174 million in the year 2024 and is projected to reach a revised size of US$ 257 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Oncology Injection Drug Market

Oncology Injection Drug Market

An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Injection Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Injection Drug.
The Oncology Injection Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Injection Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Injection Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oncology Injection Drug Market Report

Report Metric Details
Report Name Oncology Injection Drug Market
Accounted market size in year US$ 174 million
Forecasted market size in 2031 US$ 257 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Organs
  • Central Nervous System
  • Circulatory/Musculoskeletal System
  • Other
Segment by Application
  • Lymphoma
  • Myeloma
  • Prostate Cancer
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme, Eli Lilly, Praecis Pharmaceuticals, Millennium Pharmaceuticals, Debiopharm, Alza, CordenPharma, Pharmascience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oncology Injection Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Oncology Injection Drug Market growing?

Ans: The Oncology Injection Drug Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Oncology Injection Drug Market size in 2031?

Ans: The Oncology Injection Drug Market size in 2031 will be US$ 257 million.

Who are the main players in the Oncology Injection Drug Market report?

Ans: The main players in the Oncology Injection Drug Market are Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme, Eli Lilly, Praecis Pharmaceuticals, Millennium Pharmaceuticals, Debiopharm, Alza, CordenPharma, Pharmascience

What are the Application segmentation covered in the Oncology Injection Drug Market report?

Ans: The Applications covered in the Oncology Injection Drug Market report are Lymphoma, Myeloma, Prostate Cancer, Other

What are the Type segmentation covered in the Oncology Injection Drug Market report?

Ans: The Types covered in the Oncology Injection Drug Market report are Organs, Central Nervous System, Circulatory/Musculoskeletal System, Other

Recommended Reports

Cancer Drug Markets

Injectable Oncology

Cancer Therapy Advances

1 Oncology Injection Drug Market Overview
1.1 Product Definition
1.2 Oncology Injection Drug by Type
1.2.1 Global Oncology Injection Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Oncology Injection Drug by Application
1.3.1 Global Oncology Injection Drug Market Value by Application (2024 VS 2031)
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Global Oncology Injection Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Injection Drug Revenue 2020-2031
1.4.2 Global Oncology Injection Drug Sales 2020-2031
1.4.3 Global Oncology Injection Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oncology Injection Drug Market Competition by Manufacturers
2.1 Global Oncology Injection Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oncology Injection Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oncology Injection Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncology Injection Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Injection Drug, Product Type & Application
2.7 Global Key Manufacturers of Oncology Injection Drug, Date of Enter into This Industry
2.8 Global Oncology Injection Drug Market Competitive Situation and Trends
2.8.1 Global Oncology Injection Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
2.8.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncology Injection Drug Market Scenario by Region
3.1 Global Oncology Injection Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oncology Injection Drug Sales by Region: 2020-2031
3.2.1 Global Oncology Injection Drug Sales by Region: 2020-2025
3.2.2 Global Oncology Injection Drug Sales by Region: 2026-2031
3.3 Global Oncology Injection Drug Revenue by Region: 2020-2031
3.3.1 Global Oncology Injection Drug Revenue by Region: 2020-2025
3.3.2 Global Oncology Injection Drug Revenue by Region: 2026-2031
3.4 North America Oncology Injection Drug Market Facts & Figures by Country
3.4.1 North America Oncology Injection Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oncology Injection Drug Sales by Country (2020-2031)
3.4.3 North America Oncology Injection Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oncology Injection Drug Market Facts & Figures by Country
3.5.1 Europe Oncology Injection Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oncology Injection Drug Sales by Country (2020-2031)
3.5.3 Europe Oncology Injection Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Injection Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Oncology Injection Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oncology Injection Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Oncology Injection Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oncology Injection Drug Market Facts & Figures by Country
3.7.1 Latin America Oncology Injection Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oncology Injection Drug Sales by Country (2020-2031)
3.7.3 Latin America Oncology Injection Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Injection Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oncology Injection Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oncology Injection Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oncology Injection Drug Sales by Type (2020-2031)
4.1.1 Global Oncology Injection Drug Sales by Type (2020-2025)
4.1.2 Global Oncology Injection Drug Sales by Type (2026-2031)
4.1.3 Global Oncology Injection Drug Sales Market Share by Type (2020-2031)
4.2 Global Oncology Injection Drug Revenue by Type (2020-2031)
4.2.1 Global Oncology Injection Drug Revenue by Type (2020-2025)
4.2.2 Global Oncology Injection Drug Revenue by Type (2026-2031)
4.2.3 Global Oncology Injection Drug Revenue Market Share by Type (2020-2031)
4.3 Global Oncology Injection Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oncology Injection Drug Sales by Application (2020-2031)
5.1.1 Global Oncology Injection Drug Sales by Application (2020-2025)
5.1.2 Global Oncology Injection Drug Sales by Application (2026-2031)
5.1.3 Global Oncology Injection Drug Sales Market Share by Application (2020-2031)
5.2 Global Oncology Injection Drug Revenue by Application (2020-2031)
5.2.1 Global Oncology Injection Drug Revenue by Application (2020-2025)
5.2.2 Global Oncology Injection Drug Revenue by Application (2026-2031)
5.2.3 Global Oncology Injection Drug Revenue Market Share by Application (2020-2031)
5.3 Global Oncology Injection Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Taj Oncology
6.1.1 Taj Oncology Company Information
6.1.2 Taj Oncology Description and Business Overview
6.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Taj Oncology Oncology Injection Drug Product Portfolio
6.1.5 Taj Oncology Recent Developments/Updates
6.2 S.G. Biopharm
6.2.1 S.G. Biopharm Company Information
6.2.2 S.G. Biopharm Description and Business Overview
6.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
6.2.5 S.G. Biopharm Recent Developments/Updates
6.3 AdvaCare
6.3.1 AdvaCare Company Information
6.3.2 AdvaCare Description and Business Overview
6.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AdvaCare Oncology Injection Drug Product Portfolio
6.3.5 AdvaCare Recent Developments/Updates
6.4 Merrimack
6.4.1 Merrimack Company Information
6.4.2 Merrimack Description and Business Overview
6.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merrimack Oncology Injection Drug Product Portfolio
6.4.5 Merrimack Recent Developments/Updates
6.5 Celgene
6.5.1 Celgene Company Information
6.5.2 Celgene Description and Business Overview
6.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Celgene Oncology Injection Drug Product Portfolio
6.5.5 Celgene Recent Developments/Updates
6.6 Allos Therapeutics
6.6.1 Allos Therapeutics Company Information
6.6.2 Allos Therapeutics Description and Business Overview
6.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
6.6.5 Allos Therapeutics Recent Developments/Updates
6.7 Ferring Pharmaceuticals
6.7.1 Ferring Pharmaceuticals Company Information
6.7.2 Ferring Pharmaceuticals Description and Business Overview
6.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
6.7.5 Ferring Pharmaceuticals Recent Developments/Updates
6.8 Genzyme
6.8.1 Genzyme Company Information
6.8.2 Genzyme Description and Business Overview
6.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genzyme Oncology Injection Drug Product Portfolio
6.8.5 Genzyme Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Company Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Eli Lilly Oncology Injection Drug Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Praecis Pharmaceuticals
6.10.1 Praecis Pharmaceuticals Company Information
6.10.2 Praecis Pharmaceuticals Description and Business Overview
6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
6.10.5 Praecis Pharmaceuticals Recent Developments/Updates
6.11 Millennium Pharmaceuticals
6.11.1 Millennium Pharmaceuticals Company Information
6.11.2 Millennium Pharmaceuticals Description and Business Overview
6.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
6.11.5 Millennium Pharmaceuticals Recent Developments/Updates
6.12 Debiopharm
6.12.1 Debiopharm Company Information
6.12.2 Debiopharm Description and Business Overview
6.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Debiopharm Oncology Injection Drug Product Portfolio
6.12.5 Debiopharm Recent Developments/Updates
6.13 Alza
6.13.1 Alza Company Information
6.13.2 Alza Description and Business Overview
6.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Alza Oncology Injection Drug Product Portfolio
6.13.5 Alza Recent Developments/Updates
6.14 CordenPharma
6.14.1 CordenPharma Company Information
6.14.2 CordenPharma Description and Business Overview
6.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CordenPharma Oncology Injection Drug Product Portfolio
6.14.5 CordenPharma Recent Developments/Updates
6.15 Pharmascience
6.15.1 Pharmascience Company Information
6.15.2 Pharmascience Description and Business Overview
6.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Pharmascience Oncology Injection Drug Product Portfolio
6.15.5 Pharmascience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Injection Drug Industry Chain Analysis
7.2 Oncology Injection Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Injection Drug Production Mode & Process Analysis
7.4 Oncology Injection Drug Sales and Marketing
7.4.1 Oncology Injection Drug Sales Channels
7.4.2 Oncology Injection Drug Distributors
7.5 Oncology Injection Drug Customer Analysis
8 Oncology Injection Drug Market Dynamics
8.1 Oncology Injection Drug Industry Trends
8.2 Oncology Injection Drug Market Drivers
8.3 Oncology Injection Drug Market Challenges
8.4 Oncology Injection Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
ALZA
CordenPharma
Pharmascience
List of Tables
 Table 1. Global Oncology Injection Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oncology Injection Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oncology Injection Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oncology Injection Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Oncology Injection Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oncology Injection Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oncology Injection Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oncology Injection Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oncology Injection Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oncology Injection Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oncology Injection Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Oncology Injection Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oncology Injection Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oncology Injection Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Oncology Injection Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Oncology Injection Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Oncology Injection Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Oncology Injection Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oncology Injection Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Oncology Injection Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oncology Injection Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Oncology Injection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Oncology Injection Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Oncology Injection Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oncology Injection Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oncology Injection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Oncology Injection Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Oncology Injection Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oncology Injection Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oncology Injection Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oncology Injection Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Oncology Injection Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Oncology Injection Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oncology Injection Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oncology Injection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Oncology Injection Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Oncology Injection Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oncology Injection Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oncology Injection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Oncology Injection Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Oncology Injection Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oncology Injection Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oncology Injection Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Oncology Injection Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Oncology Injection Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Oncology Injection Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oncology Injection Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oncology Injection Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Oncology Injection Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Oncology Injection Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Oncology Injection Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Oncology Injection Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Oncology Injection Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Oncology Injection Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Oncology Injection Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Oncology Injection Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oncology Injection Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oncology Injection Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Oncology Injection Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Oncology Injection Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Oncology Injection Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Taj Oncology Company Information
 Table 71. Taj Oncology Description and Business Overview
 Table 72. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Taj Oncology Oncology Injection Drug Product
 Table 74. Taj Oncology Recent Developments/Updates
 Table 75. S.G. Biopharm Company Information
 Table 76. S.G. Biopharm Description and Business Overview
 Table 77. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. S.G. Biopharm Oncology Injection Drug Product
 Table 79. S.G. Biopharm Recent Developments/Updates
 Table 80. AdvaCare Company Information
 Table 81. AdvaCare Description and Business Overview
 Table 82. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. AdvaCare Oncology Injection Drug Product
 Table 84. AdvaCare Recent Developments/Updates
 Table 85. Merrimack Company Information
 Table 86. Merrimack Description and Business Overview
 Table 87. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Merrimack Oncology Injection Drug Product
 Table 89. Merrimack Recent Developments/Updates
 Table 90. Celgene Company Information
 Table 91. Celgene Description and Business Overview
 Table 92. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Celgene Oncology Injection Drug Product
 Table 94. Celgene Recent Developments/Updates
 Table 95. Allos Therapeutics Company Information
 Table 96. Allos Therapeutics Description and Business Overview
 Table 97. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Allos Therapeutics Oncology Injection Drug Product
 Table 99. Allos Therapeutics Recent Developments/Updates
 Table 100. Ferring Pharmaceuticals Company Information
 Table 101. Ferring Pharmaceuticals Description and Business Overview
 Table 102. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Ferring Pharmaceuticals Oncology Injection Drug Product
 Table 104. Ferring Pharmaceuticals Recent Developments/Updates
 Table 105. Genzyme Company Information
 Table 106. Genzyme Description and Business Overview
 Table 107. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Genzyme Oncology Injection Drug Product
 Table 109. Genzyme Recent Developments/Updates
 Table 110. Eli Lilly Company Information
 Table 111. Eli Lilly Description and Business Overview
 Table 112. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Eli Lilly Oncology Injection Drug Product
 Table 114. Eli Lilly Recent Developments/Updates
 Table 115. Praecis Pharmaceuticals Company Information
 Table 116. Praecis Pharmaceuticals Description and Business Overview
 Table 117. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Praecis Pharmaceuticals Oncology Injection Drug Product
 Table 119. Praecis Pharmaceuticals Recent Developments/Updates
 Table 120. Millennium Pharmaceuticals Company Information
 Table 121. Millennium Pharmaceuticals Description and Business Overview
 Table 122. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Millennium Pharmaceuticals Oncology Injection Drug Product
 Table 124. Millennium Pharmaceuticals Recent Developments/Updates
 Table 125. Debiopharm Company Information
 Table 126. Debiopharm Description and Business Overview
 Table 127. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Debiopharm Oncology Injection Drug Product
 Table 129. Debiopharm Recent Developments/Updates
 Table 130. Alza Company Information
 Table 131. Alza Description and Business Overview
 Table 132. Alza Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Alza Oncology Injection Drug Product
 Table 134. Alza Recent Developments/Updates
 Table 135. CordenPharma Company Information
 Table 136. CordenPharma Description and Business Overview
 Table 137. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. CordenPharma Oncology Injection Drug Product
 Table 139. CordenPharma Recent Developments/Updates
 Table 140. Pharmascience Company Information
 Table 141. Pharmascience Description and Business Overview
 Table 142. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Pharmascience Oncology Injection Drug Product
 Table 144. Pharmascience Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Oncology Injection Drug Distributors List
 Table 148. Oncology Injection Drug Customers List
 Table 149. Oncology Injection Drug Market Trends
 Table 150. Oncology Injection Drug Market Drivers
 Table 151. Oncology Injection Drug Market Challenges
 Table 152. Oncology Injection Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oncology Injection Drug
 Figure 2. Global Oncology Injection Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Injection Drug Market Share by Type: 2024 & 2031
 Figure 4. Organs Product Picture
 Figure 5. Central Nervous System Product Picture
 Figure 6. Circulatory/Musculoskeletal System Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Oncology Injection Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Oncology Injection Drug Market Share by Application: 2024 & 2031
 Figure 10. Lymphoma
 Figure 11. Myeloma
 Figure 12. Prostate Cancer
 Figure 13. Other
 Figure 14. Global Oncology Injection Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Oncology Injection Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Oncology Injection Drug Sales (2020-2031) & (K Pcs)
 Figure 17. Global Oncology Injection Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Oncology Injection Drug Report Years Considered
 Figure 19. Oncology Injection Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Oncology Injection Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Oncology Injection Drug Players: Market Share by Revenue in Oncology Injection Drug in 2024
 Figure 22. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Oncology Injection Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Oncology Injection Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Oncology Injection Drug Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Oncology Injection Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Oncology Injection Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Oncology Injection Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Oncology Injection Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Oncology Injection Drug Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Oncology Injection Drug Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Oncology Injection Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Oncology Injection Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Oncology Injection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Oncology Injection Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Oncology Injection Drug by Type (2020-2031)
 Figure 59. Global Oncology Injection Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Oncology Injection Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Oncology Injection Drug by Application (2020-2031)
 Figure 62. Global Oncology Injection Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Oncology Injection Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Doxorubicin Injection Market Research Report 2024
Global Anti tumor Injection Market Research Report 2024
Cancer Treatment Drugs Market
Global Oncology Targeted Therapy Market Research Report 2025
Global Oncology Generic Injectable Drugs Market Research Report 2024
Global Cancer Targeted Drug Market Research Report 2025
Global Targeted Chemotherapy Drugs Market Research Report 2024
Global Medication Management in Oncology Market Research Report 2025
Global Targeted Small Molecule Drug Market Research Report 2025
Global Injectable Cytotoxic Drugs Market Research Report 2024
Global Anticancer Drugs Market Research Report 2025
Global Targeted Oncology Drugs Market Research Report 2024
Global Oncology and Cancer Treatment Drug Market Research Report 2024
Global Chemotherapy Inject Medicine Pump Market Research Report 2024
Global Injectable Targeted Therapy Market Research Report 2024
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Chemotherapy Drug Market Insights Forecast to 2030
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Oncology Adjuvants Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions